Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease
Polish Archives of Internal Medicine · 2023
DOI: 10.20452/pamw.16566 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polish Archives of Internal Medicine, 2023. Verfasst von Leonardo De Luca. Beteiligte Einrichtung: Department of Cardio-Thoracic and Vascular Medicine and Surgery, Division of Cardiology, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy. leo.…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Peripheral Arterial Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardio-Thoracic and Vascular Medicine and Surgery, Division of Cardiology, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy. leo.deluca@libero.it
Zitieren
APA
De Luca, L. (2023). Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16566
Vancouver
De Luca L. Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease. Polish Archives of Internal Medicine. 2023. doi:10.20452/pamw.16566
BibTeX
@article{DeLuca2023,
author = {De Luca, Leonardo},
title = {Who may benefit from low-dose Rivaroxaban plus Aspirin? Practical implications for outpatients with cardiovascular disease},
journal = {Polish Archives of Internal Medicine},
year = {2023},
doi = {10.20452/pamw.16566}
}
EUVIMED